Lv4
654 积分 2021-09-22 加入
Phase I study of procaspase activating compound-1 (PAC-1) in the treatment of advanced malignancies
1天前
待确认
Understanding the Interplay between oHSV and the Host Immune System: Implications for Therapeutic Oncolytic Virus Development
1天前
待确认
Design, Synthesis, and Biological Evaluation of Novel Orally Available Covalent CDK12/13 Dual Inhibitors for the Treatment of Tumors
9天前
已完结
Discovery and resistance mechanism of a selective CDK12 degrader
10天前
已完结
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
10天前
已完结
MYC in cancer: from undruggable target to clinical trials
22天前
已完结
Progress in the development of ERK1/2 inhibitors for treating cancer and other diseases
23天前
已完结
Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors
25天前
已完结
Protein degraders push into novel target space
1个月前
已完结
Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)
1个月前
已完结
Daptomycin
3年前
已采纳
利用CT图像勾画前列腺癌尖部的研究
3年前
已采纳
成人口服营养补充专家共识
3年前
已采纳
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
3年前
已采纳
Primary treatment and Recent survival trends in patients with Primary Diffuse Large B-Cell Lymphoma of Central Nervous System,1995-2016: a population-based SEER analysis
3年前
已采纳
Primary treatment and Recent survival trends in patients with Primary Diffuse Large B-Cell Lymphoma of Central Nervous System,1995-2016: a population-based SEER analysis
3年前
已驳回
《临床超声医学杂志》
3年前
已采纳
皖公网安备34019202002308
